Lupus Mutation May Unlock Targeted Drugs for Patient Subset

Noa Schwartz, M.D., M.S., comments on the discovery of a rare mutation in a person with systemic lupus erythematosus and the possibility that it could lead to new treatments for a subset of patients with the disease. Dr. Schwartz is assistant professor of medicine at Einstein and director of the Montefiore-Einstein Institute for Lupus Care and Research.